Orforglipron is usually a day-to-day capsule that only targets GLP-one. It’s a “tiny molecule,” which suggests it may possibly survive digestion and become absorbed by the body, while more substantial peptide medication like tirzepatide would be damaged down within the belly and has to be injected.以下溶解方案都请先按照体外实验